Artboard 33atençãoArtboard 18atualizarconectividadeArtboard 42boletocarrinhocartãoArtboard 45cartão SaraivacelularArtboard 42Artboard 23checkArtboard 28Artboard 17?compararcompartilharcompartilhar ativoArtboard 28Artboard 43Artboard 49Artboard 47Artboard 15Artboard 32ebookArtboard 22Artboard 5Artboard 25Artboard 1Artboard 42Artboard 11fecharfilmesArtboard 23gamesArtboard 4Artboard 9Artboard 6hqimportadosinformáticaArtboard 7Artboard 3Artboard 12Artboard 25Artboard 34Artboard 43Artboard 44curtirArtboard 24Artboard 13livrosArtboard 24Artboard 31menumúsicaArtboard 27Artboard 30Artboard 36Artboard 44outrospapelariaArtboard 17Artboard 6Artboard 27Artboard 30Artboard 29Artboard 26Artboard 2Artboard 20Artboard 35estrelaestrela ativorelógiobuscaArtboard 50Artboard 26toda saraivaArtboard 40Artboard 21Artboard 10Artboard 37usuárioArtboard 46Artboard 33Artboard 8seta
e-book

Transforming Big Pharma - Assessing the Strategic Alternatives (Cód: 9540293)

Ansell,John

Taylor & Francis Ltd (Livros Digitais)

Ooops! Este produto não está mais a venda.
Mas não se preocupe, temos uma versão atualizada para você.

Ooopss! Este produto está fora de linha, mas temos outras opções para você.
Veja nossas sugestões abaixo!

R$ 374,85

em até 10x de R$ 37,49 sem juros

Total:

Em até 1x sem juros de


Crédito:
Boleto:
Cartão Saraiva:

Total:

Em até 10x sem juros de


Transforming Big Pharma - Assessing the Strategic Alternatives

R$374,85

Descrição

In Transforming Big Pharma John Ansell addresses critically how strategy works in the pharmaceutical industry. The long-standing dearth of new products has led to a growing shortfall in revenues. Ansell assesses the wide range of alternative strategies big pharma companies have been pursuing in recent years in attempting to overcome this. He shows that there is sound evidence to expect the recent upturn in the number of new products reaching the market to go on to greater heights. Chapters assess the complex trends in attrition rates, show how rife spectacular sales underestimation in the industry remains, and explain how conventional wisdom on the chances of product profitability also seriously undersells the industry. The surest route to transforming the prospects for big pharma, Ansell contends, is to step up activity in acquiring and developing new products. This is now realistic because, as he shows, the amount of intellectual property available is much greater than it was a decade ago. Ansell believes that no other strategies have sufficient transformative powers, though they may be useful as a stopgap whilst the sales of forthcoming new products mature. He argues for a reversal of big pharma's recent cutbacks in R&D and licensing, and re-focussing on new product development. Transforming Big Pharma is intended for those in senior and middle management in the pharmaceutical industry. It will also be valuable to students, as well as to all those dealing with the industry, including biotech companies and those providing services and products to the pharmaceutical industry.

Características

Produto sob encomenda Não
Marca Taylor & Francis Ltd (Livros Digitais)
Cód. Barras 9781317007715
Acabamento e-book
Início da Venda 24/02/2016
Territorialidade Internacional
Formato Livro Digital Epub
Gratuito Não
Tamanho do Arquivo 2908
Proteção Drm Sim
Idioma 337
Código do Formato Epub
Número de Páginas 284 (aproximado)
Ano da Publicação 116
Peso 0.00 Kg
AutorAnsell,John